Vanguard Group Inc Summit Therapeutics Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,673,672 shares of SMMT stock, worth $160 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,673,672

Previous 11,640,507 25.49%

Holding current value

$160 Million

Previous $225 Million 17.8%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$16.64 - $36.7 $49.4 Million - $109 Million	-2,966,835 Reduced 25.49%	8,673,672 $185 Million
Q1 2025 May 09, 2025	SELL	$16.65 - $23.76 $500,648 - $714,439	-30,069 Reduced 0.26%	11,640,507 $225 Million
Q4 2024 Feb 11, 2025	BUY	$17.52 - $23.46 $12.7 Million - $17 Million	724,040 Added 6.61%	11,670,576 $208 Million
Q3 2024 Nov 13, 2024	BUY	$6.89 - $31.93 $14.7 Million - $67.9 Million	2,128,073 Added 24.13%	10,946,536 $240 Million
Q2 2024 Aug 13, 2024	BUY	$2.39 - $10.92 $3.7 Million - $16.9 Million	1,549,220 Added 21.31%	8,818,463 $68.8 Million
Q1 2024 May 10, 2024	BUY	$2.55 - $5.07 $648,365 - $1.29 Million	254,261 Added 3.62%	7,269,243 $30.1 Million
Q4 2023 Feb 14, 2024	BUY	$1.67 - $2.83 $1.54 Million - $2.6 Million	919,307 Added 15.08%	7,014,982 $18.3 Million
Q3 2023 Nov 14, 2023	SELL	$1.54 - $2.42 $7,415 - $11,652	-4,815 Reduced 0.08%	6,095,675 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$1.32 - $2.81 $6.12 Million - $13 Million	4,635,361 Added 316.38%	6,100,490 $15.3 Million
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $29,767 - $116,699	21,571 Added 1.49%	1,465,129 $2.56 Million
Q4 2022 Feb 10, 2023	BUY	$0.68 - $5.31 $453,992 - $3.55 Million	667,636 Added 86.04%	1,443,558 $6.14 Million
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $124,636 - $322,428	-135,474 Reduced 14.86%	775,922 $776,000
Q1 2022 May 13, 2022	BUY	$2.0 - $3.45 $9,018 - $15,556	4,509 Added 0.5%	911,396 $2.23 Million
Q4 2021 Feb 14, 2022	BUY	$2.45 - $5.64 $3,324 - $7,653	1,357 Added 0.15%	906,887 $2.44 Million
Q3 2021 Nov 12, 2021	BUY	$4.83 - $8.27 $123,802 - $211,976	25,632 Added 2.91%	905,530 $4.54 Million
Q2 2021 Aug 13, 2021	BUY	$5.15 - $8.46 $4.53 Million - $7.44 Million	879,898 New	879,898 $6.56 Million

Others Institutions Holding SMMT

# of Institutions

259

Shares Held

90.4M

Call Options Held

4.71M

Put Options Held

3.17M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.7B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Summit Therapeutics Inc. Transaction History